Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: TickerHound who wrote (3553)	5/26/1998 4:28:00 PM
From: BAD BILLY	Read Replies (1) \| Respond to of 3906

Well all I can say is there are a hand full of ED drugs out there and they all have there pros and cons, but no one is dominating. It would be interesting to see how HVSF would compare. All aspects of the drug seem to be superior to the competition, but its unapproved. You know what they say last but not least ? I think PFE is over hyped in a big way and other more functional drugs will eventually gain more of the mkt share. Catch ya later Ticker.